Curia’s Post

In the complex treatment landscape of Inflammatory Bowel Disease (IBD), Baysient is at the forefront of optimizing biologic therapy. A recent summarization of the pharmacokinetics of monoclonals from Deyhim et al., published in the Journal of Clinical Medicine in 2023, highlights the critical role of drug clearance in determining the effectiveness of biologics for IBD patients. 📊 Key Findings ▪️ Factors like body weight, serum albumin levels, and immunogenicity significantly impact biologic clearance. ▪️ Model Informed Precision Dosing (MIPD) tools, using clearance data, can personalize dosing to reach target drug concentrations, enhancing treatment outcomes. 👩⚕️ Baysient's Role Our approach integrates these insights, using advanced modeling to predict optimal dosing for each patient. This method not only improves response rates but also reduces complications and enhances drug efficacy. 🌐 Read more about this review and how Baysient's technology is shaping personalized IBD care: https://bit.ly/3OoNf16. #IBDCare #Biologics #PrecisionMedicine #TDM

Vivian Y. Shi, MD, FAAD, examines recent data on the biologic bimekizumab for treatment of hidradenitis suppurativa in this #Insights episode. Learn more about the promising results with this video: https://bit.ly/4cGpRFz #HidradenitisSuppurativa #Biologics

🚀The FDA Approves New Biosimilars 🌟 Advancement in Medication Accessibility: Recent FDA approval accelerates the availability of cutting-edge biosimilar medications. FDA's Role: Ensures rigorous science backed regulatory processes, confirming the safety and efficacy for patient treatments. Patient Benefits: Expanded treatment options coupled with potential cost savings in healthcare. Highlighted Success Stories: - Avzivi as an alternative to Avastin (December) - Wezlana follows Stelara (October) - Tofidence akin to Actemra (September) - Tyruko substitutes Tysabri (August) - Yuflyma parallels Humira (May) Resource Alert: Discover comprehensive biosimilar data within the Purple Book Database. Essential information on allergenic, therapy, hematologic products, and vaccines approved by the FDA is available here [FDA Biosimilar Product Information] https://lnkd.in/dNKwkKxp) Engagement Call-to-Action: How will biosimilars transform our healthcare system? Share your insights below. #FDAApproval #Biosimilars #HealthCareInnovation

Hello Connections! 🌟 I’ve just completed the " An Introduction to Pharmacogenomics for Pharmacists" course from CEimpact. This course provided a comprehensive overview of how genetic variations impact drug responses and how pharmacogenomics can be integrated into clinical practice to enhance patient care. I'm thrilled to apply this knowledge to optimize medication therapy and improve patient outcomes. #Pharmacogenomics #Pharmacy #PersonalizedMedicine #CEimpact #ProfessionalGrowth

Are You Ready To Tackle #ELISA For Your #Pharmacokinetics, #Immunogenicity, #Cytokine, #Biomarker, Or #Potency #MOA Assessments: Rely On Our 20+ Years Track Record To Streamline Your Journey Towards Safe And Efficacious #Biologics Or #CellAndGene Therapy! 🧪 Tailored #PK, ADA #TAb / #NAb Assays: Engineered To Align With Your Unique Research Parameters And Deliver High-Quality Data Plus Reports That Meet Your Expectations. 🕑 Flexible, Transparent, And Rapid Turnaround: Streamlined Workflows For Prompt Results, Maintaining Stringent Accuracy. 🔬Cutting-Edge Expertise And Resources: Harness #MesoScaleDiscovery, #Luminescence, Or #AlphaLISA For Comprehensive #In-Vivo Or #In-Vitro Analysis. 🏆 Gold-Standard Compliance: #GLP Protocols Translate To Dependable, Superior Results While Following Industry Standards And Best Practices. Accelerate Your Therapeutics Development: Engage With Our Seasoned Scientists For Bespoke #Bioanalytical #Immunoassay Strategies. 🔗https://lnkd.in/dw2ra3KM

Check out the earliest article on Psoriasis available on Pubmed from 1801! It's fascinating to see the differences in language, treatments provided, and the article prints even the patient's name!, Starting from this and today we have 64,961 articles for a simple search on Psoriasis! Just a quick simple step back in time and appreciate the works of the giants (patients, physicians, nurses, NP, scientists, research personnel, Industry personnel) in our field who paved the way for the work we are able to do today with biologics. Looking back can be just as valuable as looking forward. #Pubmed #Psoriasis #MedicalHistory #Biologics #WeekendReads

Is your organization planning to cover American College of Rheumatology (ACR Convergence 2024) in Washington from 14-19th November?   Stay ahead of the curve with RCG Intel! Our team of seasoned professionals have been in your shoes. We will keep track of key market developments, highlight implications to your organization, provide organizational tailored potential calls to action, and elucidate severity of the impact to the future marketplace.                        See below a current snapshot the #US and #EU landscape for Psoriatic Arthritis (PsA), showcasing early and late-stage clinical developments along with approved blockbuster biologics like #Stelara, #Humira, #Cosentyx, #Enbrel, #Simponi, and new entrances such as #Bimzelx.   Book a meeting now to discuss how this marketplace will evolve: https://lnkd.in/gE-uQb3D #Pharma #Rheumatology #PsoriaticArthritis #ACRConvergence2024 #Biologics #ClinicalTrials #HealthcareInnovation #PharmaTrends #MarketAnalysis #DigitalHealth #MedicalResearch #PharmaMarketing #HealthcareConsulting #FutureOfMedicine #PharmaInsights #competitiveintelligence

💡 Understanding the landscape is just the beginning. ⏳ With **ACR fast approaching**, now is the moment to solidify your team's readiness for comprehensive coverage, focused insights, and personalized analysis. 🤝 For the past 5 years, our team members have been a trusted partner at this conference. Let us guide you through your conference coverage strategy. 📅 **Book a meeting now** to discuss how this marketplace will evolve:   🔗 [https://lnkd.in/gyfnMvyZ) #Pharma #Rheumatology #PsoriaticArthritis #ACRConvergence2024 #Biologics #ClinicalTrials #HealthcareInnovation #PharmaTrends #MarketAnalysis #DigitalHealth #MedicalResearch #PharmaMarketing #HealthcareConsulting #FutureOfMedicine #PharmaInsights #CompetitiveIntelligence

Visualizing the market landscape is the crucial first step toward gaining a deeper understanding of any industry. Medical conferences, in particular, offer an excellent opportunity to expand your knowledge of specific therapeutic areas while staying updated on emerging trends and developments. Our team has consistently attended the American College of Rheumatology annual conference over the years, fostering strong connections with key opinion leaders (#KOLs) in the field of rheumatology. At RCG Intel, our seasoned team provides tailored support, offering comprehensive conference coverage, focused insights, and personalized analyses to help you navigate your strategic objectives with clarity and confidence. Reach out to us for any medical conference coverage needs. Drew Fussner, MBA (drew@rcgintel.com) Joseph Luminiello (joe@rcgintel.com) Karan Kalra (karan@rcgintel.com) #Pharma #Rheumatology #PsoriaticArthritis #ACRConvergence2024 #Biologics #ClinicalTrials #arthritis #lupus #SLE #Sjogrens #HealthcareInnovation #PharmaTrends #MarketAnalysis #DigitalHealth #MedicalResearch #PharmaMarketing #HealthcareConsulting #FutureOfMedicine #PharmaInsights #CompetitiveIntelligence

Pooled CAR T high throughput screening is now possible. Screen up to thousands of CAR T candidates in one microtiter plate. #biologics #screening #immunotherapy #cartcelltherapy #cellandgenetherapy #tcells #enrichment #highthroughput #singlecell #clone #singlecellanalysis #til #cancerresearch #cancerbiology #celltherapy #celltherapymanufacturing #tcr